Search

Search Constraints

You searched for: Author/Creator Warner, Andrew

Search Results

21. 88: The use of Respiratory Gating for Delivery of Stereotactic Ablative Radiotherapy (SABR): Is there an Impact on Oncologic Outcomes?. (September 2016)

22. 91 Quality of Life Outcomes After Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care Palliative Treatments: A Secondary Analysis of the SABR-COMET Randomized Trial. (October 2019)

23. 92 Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-COMET. (October 2019)

26. A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis. Issue 3 (March 2016)

27. Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid 18F‐fluorodeoxyglucose‐positron emission tomography and CT perfusion study. Issue 1 (3rd October 2018)

28. Can radiological changes in lymph node volume during treatment predict success of radiation therapy in patients with locally advanced head and neck squamous cell carcinoma?. Issue 5 (8th May 2013)

29. Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1. Issue 1 (28th August 2019)

30. Development, Implementation, and Initial Participant Feedback of an Online Anatomy and Radiology Contouring Bootcamp in Radiation Oncology. (September 2021)